BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38691814)

  • 41. A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol.
    Sharma A; Johnson KB; Bie B; Rhoades EE; Sen A; Kida Y; Hockings J; Gatta A; Davenport J; Arcangelini C; Ritzu J; DeVecchio J; Hughen R; Wei M; Thomas Budd G; Lynn Henry N; Eng C; Foss J; Rotroff DM
    Technol Cancer Res Treat; 2022; 21():15330338221127169. PubMed ID: 36172750
    [No Abstract]   [Full Text] [Related]  

  • 42. The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry.
    Beijers AJ; Oerlemans S; Mols F; Eurelings M; Minnema MC; Vreugdenhil A; van de Poll-Franse LV
    Ann Hematol; 2017 Apr; 96(4):653-663. PubMed ID: 28116479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study.
    Pereira S; Fontes F; Sonin T; Dias T; Fragoso M; Castro-Lopes JM; Lunet N
    Support Care Cancer; 2016 Apr; 24(4):1571-81. PubMed ID: 26384827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.
    Cavaletti G; Cornblath DR; Merkies ISJ; Postma TJ; Rossi E; Frigeni B; Alberti P; Bruna J; Velasco R; Argyriou AA; Kalofonos HP; Psimaras D; Ricard D; Pace A; Galiè E; Briani C; Dalla Torre C; Faber CG; Lalisang RI; Boogerd W; Brandsma D; Koeppen S; Hense J; Storey D; Kerrigan S; Schenone A; Fabbri S; Valsecchi MG; ; Mazzeo A; Pace A; Pessino A; Schenone A; Toscano A; Argyriou AA; Brouwer B; Frigeni B; Piras B; Briani C; Dalla Torre C; Dominguez Gonzalez C; Faber CG; Tomasello C; Binda D; Brandsma D; Cortinovis D; Psimaras D; Ricard D; Storey D; Cornblath DR; Galiè E; Lindeck Pozza E; Rossi E; Vanhoutte EK; Lanzani F; Pastorelli F; Altavilla G; Cavaletti G; Granata G; Kalofonos HP; Ghignotti I; Merkies ISJ; Bruna J; Hense J; Heimans JJ; Mattavelli L; Padua L; Reni L; Bakkers M; Boogerd M; Campagnolo M; Cazzaniga M; Eurelings M; Leandri M; Lucchetta M; Penas Prado M; Russo M; Valsecchi MG; Piatti ML; Alberti P; Bidoli P; Grant R; Plasmati R; Velasco R; Lalisang RI; Meijer RJ; Fabbri S; Dorsey SG; Galimberti S; Kerrigan S; Koeppen S; Postma TJ; Boogerd W; Grisold W
    Ann Oncol; 2013 Feb; 24(2):454-462. PubMed ID: 22910842
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data.
    Smith EML; Banerjee T; Yang JJ; Bridges CM; Alberti P; Sloan JA; Loprinzi C
    Cancer Nurs; 2019; 42(3):179-189. PubMed ID: 29649081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electroacupuncture use for treatment of taxane-induced peripheral neuropathy in patients with breast cancer: protocol for a pilot, randomised, blinded, sham-controlled trial (EA for CIPN).
    Choi V; Park SB; Lacey J; Kumar S; Heller G; Grimison P
    BMJ Open; 2024 Jan; 14(1):e076391. PubMed ID: 38195173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel.
    Ventzel L; Jensen AB; Jensen AR; Jensen TS; Finnerup NB
    Pain; 2016 Mar; 157(3):560-568. PubMed ID: 26529271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221).
    Mongiovi JM; Zirpoli GR; Cannioto R; Sucheston-Campbell LE; Hershman DL; Unger JM; Moore HCF; Stewart JA; Isaacs C; Hobday TJ; Salim M; Hortobagyi GN; Gralow JR; Thomas Budd G; Albain KS; Ambrosone CB; McCann SE
    Breast Cancer Res; 2018 Nov; 20(1):146. PubMed ID: 30486865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Wireless Transcutaneous Electrical Nerve Stimulation (TENS) for Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Proof-of-Concept Randomized Clinical Trial.
    Gewandter JS; Culakova E; Davis JN; Gada U; Guido JJ; Bearden JD; Burnette B; Shah D; Morrow GR; Mustian K; Sluka KA; Mohile N
    J Pain; 2024 May; 25(5):104431. PubMed ID: 37993030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire.
    Lavoie Smith EM; Barton DL; Qin R; Steen PD; Aaronson NK; Loprinzi CL
    Qual Life Res; 2013 Dec; 22(10):2787-99. PubMed ID: 23543373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physical function as a predictor of chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.
    Lin KY; Chen PS; Lin CF
    BMC Gastroenterol; 2024 May; 24(1):154. PubMed ID: 38711006
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20.
    Postma TJ; Aaronson NK; Heimans JJ; Muller MJ; Hildebrand JG; Delattre JY; Hoang-Xuan K; Lantéri-Minet M; Grant R; Huddart R; Moynihan C; Maher J; Lucey R;
    Eur J Cancer; 2005 May; 41(8):1135-9. PubMed ID: 15911236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review.
    Timmins HC; Mizrahi D; Li T; Kiernan MC; Goldstein D; Park SB
    J Cancer Surviv; 2023 Feb; 17(1):222-236. PubMed ID: 33438175
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient factors associated with discrepancies between patient-reported and clinician-documented peripheral neuropathy in women with breast cancer receiving paclitaxel: A pilot study.
    Salgado TM; Liu J; Reed HL; Quinn CS; Syverson JG; Le-Rademacher J; Lopez CL; Beutler AS; Loprinzi CL; Vangipuram K; Smith EML; Henry NL; Farris KB; Hertz DL
    Breast; 2020 Jun; 51():21-28. PubMed ID: 32193049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives.
    Ewertz M; Qvortrup C; Eckhoff L
    Acta Oncol; 2015 May; 54(5):587-91. PubMed ID: 25751757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of high-risk drugs related to chemotherapy-induced peripheral neuropathy in Cancer Therapy Evaluation Program-sponsored phase I trials.
    Kishimoto S; Oshima N; Rinker M; Krishna MC; Takebe N
    Eur J Cancer; 2019 Jul; 115():111-119. PubMed ID: 31132741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is CT-based body composition associated with long-term chemotherapy-induced peripheral neuropathy in colorectal cancer survivors?
    Smit D; Mols F; Bonhof CS; Bours MJL; Vreugdenhil G; Beijer S
    Support Care Cancer; 2022 Jul; 30(7):6071-6078. PubMed ID: 35416503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy.
    Molassiotis A; Cheng HL; Lopez V; Au JSK; Chan A; Bandla A; Leung KT; Li YC; Wong KH; Suen LKP; Chan CW; Yorke J; Farrell C; Sundar R
    BMC Cancer; 2019 Feb; 19(1):132. PubMed ID: 30736741
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors.
    Gewandter JS; Mohile SG; Heckler CE; Ryan JL; Kirshner JJ; Flynn PJ; Hopkins JO; Morrow GR
    Support Care Cancer; 2014 Jul; 22(7):1807-14. PubMed ID: 24531792
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Randomized, Placebo-Controlled Trial Evaluating Changes in Peripheral Neuropathy and Quality of Life by Using Low-Frequency Electrostimulation on Breast Cancer Patients Treated With Chemotherapy.
    Song SY; Park JH; Lee JS; Kim JR; Sohn EH; Jung MS; Yoo HS
    Integr Cancer Ther; 2020; 19():1534735420925519. PubMed ID: 32493088
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.